| 1/7 | US=6 / Quimioterapia Airley R. Histone deacetylase: an epigenetic drug target. In: ___. Cancer chemotherapy: basic science to the clinic. New Jersey: John Wiley & Sons, 2009. p. 255-63. ISBN 978-0-470-09254-5. INIBIDORES DE HDAC; HISTONA DEACETILASE; DROGA EPIGENETICA; HDAC; EMBALAGEM DE DNA |
| 2/7 | US=39 / Câncer Rosato RR, Grant S. Histone deacetylase inhibitors and anticancer activity. In: Bonavida B. Sensitization of cancer cells for chemo/immuno/radio-therapy. Los Angeles: Humana Press, 2008. p. 115-31. ISBN 978-1-58829-989-5. INIBIDORES HISTONA DEACETILASE; ATIVIDADE ANTICANCER; MECANISMO MOLECULAR; EPIGENETICA |
| 3/7 | US=80 / Biol/Mol Gjertsen BT, Sjoholt G. Proteomic strategies of therapeutic individualization and target discovery in acute myeloid leukemia. In: Daoud SS. Cancer proteomics from bench to bedside. New Jersey: Humana press, 2008. p. 161-87. (Cancer Drug Discovery and Development) ISBN 978-1-59745-169-7. LEUCEMIA MIELOIDE AGUDA; BIOMARCADORES; PHARMACOPROTEOMICS; ACIDO TRANS-RETINOICO; INIBIDORES DE QUINASE DE TIROSINA; HISTONA DEACETILASE INIBIDORES; INIBIDORES DE PROTEASSOMA |
| 4/7 | US=35 / Câncer Fandy T, Carraway H, Gore SD. Molecular therapeutics of AML: modulating gene expression as a therapeutic approach in the treatment of AML. In: Karp JE. Acute myelogenous leukemia. New Jersey: Humana Press, 2007. p. 275-91. (Contemporary Hematology) ISBN 978-1-58829-621-4. LEUCEMIA MIELOIDE AGUDA; METILACAO DO DNA; AGENTE DEMETILANTE; 5-AZACITIDINA; INIBIDOR DA HISTONA DEACETILASE; PROMOTOR HIPER-METILACAO; HISTONA ACETILTRANSFERASE; HISTONA METILTRANSFERASE; DECITABINA |
| 5/7 | US=88 / Biol/Mol Ao A, Lu J. Proteins that alter histone modifications in cancer. In: Tollefsbol T. Cancer epigenetics. Boca Raton: CRC, 2009. p. 181-95. ISBN 978-1-4200-4579-6. CANCER; EPIGENETICA; PROTEINAS; HISTONAS; ACETILTRANSFERASE; DEACETILASE; METILTRANSFERASE |
| 6/7 | US=88 / Biol/Mol Sargeant AM, Kulp SK, Lu YS, Cheng AL, Chen CS. Histone deacetylase inhibitors in cancer therapy. In: Tollefsbol T. Cancer epigenetics. Boca Raton: CRC, 2009. p. 381-98. ISBN 978-1-4200-4579-6. CANCER; EPIGENETICA; INIBIDORES DA HISTONA DEACETILASE; CANCER. TERAPIA |
| 7/7 | US=2-A / Biol/Mol Marks PA. Molecular targets and therapeutics: histone deacetylase inhibitors: development as anticancer agents. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 1014-32. ISBN 978-3-527-31237-5. ALVOS MOLECULARES; TERAPEUTICA MOLECULAR; INIBIDORES DE HISTONA DEACETILASE; AGENTES ANTICANCER; ESTRUTURA DA CROMATINA; HDAC; ENSAIOS CLINICOS |